Sepsis Diagnostic Markets. Global Market Forecasts by Assay, by Cause, by Product, by Lab, and by Place. With Executive and Consultant Guides. 2025

Over 45 million people a year suffer from sepsis but surprisingly there is no definitive diagnostic. The race is on using all the genomic and molecular diagnostic tools that have come to the fore in the last decade.

Will Artificial Intelligence play a role?

It is not clear who will be the winner, but the stakes are global and large. Emergency life saving diagnostics can command a premium price in the market. Understand the different drivers of this huge global diagnostic market and find where the opportunities lie.

Our facts and support = Your success.

The report forecasts the market size out for five years. Growth is coming from the basic factors related to improving levels of health care throughout the world. In addition the legacy of the pandemic has changed the playing field for respiratory infections. Some players have already made their mark but disruptive diagnostic technology could change the playing field. Learn about this market including the issues and outlooks. The two key trends of Rapid Diagnostics and the Genomics Revolution are merging to create new diagnostic opportunities.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

1. Market Guides

1.1. Situation Analysis
1.2. Guide for Executives and Marketing Staff
1.3. Guide for Investment Analysts and Management Consultants

2. Introduction and Market Definition

2.1. An Overview of Sepsis Diagnostics
- 2.1.1. Sepsis the medical emergency
- 2.1.2. Sepsis Diagnosis and Comorbidity
2.2. Market Definition
- 2.2.1. Market Size
- 2.2.2. Currency
- 2.2.3. Years
- 2.2.4. Microbiology
- 2.2.5. PCR
- 2.2.6. Immunoassay
- 2.2.7. Other Infectious Disease
- 2.2.8. Syndromic PoC
- 2.2.9. Biomarkers Molecular Diagnostics
- 2.2.10. Biomarkers Other
- 2.2.11. Limitations
2.3. Methodology
- 2.3.1. Methodology
- 2.3.2. Sources
- 2.3.3. Authors
2.4. Perspective: Healthcare and the IVD Industry
- 2.4.1. Global Healthcare Spending
- 2.4.2. Spending on Diagnostics
- 2.4.3. Important Role of Insurance for Diagnostics

3. Sepsis - Current Science

3.1. What is Sepsis?
- 3.1.1. Organ Damage
- 3.1.2. Neonatal sepsis
- 3.1.3. Prognosis
3.2. Diagnosis
- 3.2.1. Infection Identification
- 3.2.2. Biomarkers
- 3.2.3. Differential diagnosis
- 3.2.4. The Cytokine Storm - Diagnostic Needs
3.3. Causes of Sepsis
- 3.3.1. Sepsis Progression
- 3.3.2. The Cytokine Storm - COVID and Other Situations
3.4. Prevalence
- 3.4.1. Impact of COVID on Sepsis Prevalence

4. Industry Overview

4.1. Players in a Dynamic Market
- 4.1.1. Academic Research Lab
- 4.1.2. Diagnostic Test Developer
- 4.1.3. Instrumentation Supplier
- 4.1.4. Chemical/Reagent Supplier
- 4.1.5. Pathology Supplier
- 4.1.6. Independent Clinical Laboratory
- 4.1.7. Public National/regional Laboratory
- 4.1.8. Hospital Laboratory
- 4.1.9. Physicians Office Lab (POLS)
- 4.1.10. Audit Body
- 4.1.11. Certification Body

5. Market Trends

5.1. Factors Driving Growth
- 5.1.1. Increasing Prevalence
- 5.1.2. Antimicrobial Resistance
- 5.1.3. Artificial Intelligence Impact
- 5.1.4. Multiplex Diagnostics Impacts
- 5.1.5. The Aging World
- 5.1.6. Developing World Impact
5.2. Factors Limiting Growth
- 5.2.1. The Cost Curve Shrinks the Market
- 5.2.2. The Diagnostics Dillemma
- 5.2.3. Adoption Lag and Cost Control
5.3. Instrumentation, Automation and Diagnostic Trends
- 5.3.1. Traditional Automation and Centralization
- 5.3.2. The New Automation, Decentralization and Point Of Care
- 5.3.3. Instruments Key to Market Share
- 5.3.4. Bioinformatics Plays a Role
- 5.3.5. PCR Takes Command
- 5.3.6. Next Generation Sequencing Fuels a Revolution
- 5.3.7. NGS Impact on Pricing
- 5.3.8. Whole Genome Sequencing, A Brave New World
- 5.3.9. Companion Diagnostics Blurs Diagnosis and Treatment
- 5.3.10. Shifting Role of Diagnostics
- 5.3.11. The Next Five Years

6. Sepsis Diagnostics - Recent Developments

6.1. Recent Developments - Importance and How to Use This Section
- 6.1.1. Importance of These Developments
- 6.1.2. How to Use This Section
6.2. FDA Clears Abionic's Sepsis Test
6.3. MicrosensDx to develop sepsis test
6.4. Cytovale's sepsis diagnostic test shows results
6.5. Inflammatix Completes Sepsis Test System
6.6. Microplate Dx to Launch UTI Susceptibility Test
6.7. QC for DiaSorin's Luminex Sepsis Tests Cleared
6.8. Cytovale IntelliSep
6.9. Prenosis to Study Sepsis in Acute Care
6.10. DiaSorin Gains CE Mark for Sepsis Assay
6.11. Cytovale to Launch Sepsis Risk-Scoring Test
6.12. Todos Medical to Offer Sepsis PCR Test
6.13. SeptiCyte-R RAPID Validated
6.14. Cepheid Group B Strep Test Addresses Neonatal Sepsis
6.15. DeepUll Inks Financing Deal
6.16. Sequencing-Based Approach Shows Promise for Sepsis Dx
6.17. VolitionRx Studies Cancer, Sepsis Tests
6.18. Cytovale Prepping Sepsis Test for FDA Submission
6.19. Great North R & I to Develop POC Sepsis Dx
6.20. Pathogenomix Developing Sepsis Testing Platform
6.21. Gradientech Launches Study of AST System
6.22. Sepsis Test Developers Accelerate Plans
6.23. Immunexpress Receives Clearance for Sepsis Assay
6.24. Prenosis, Roche Partner on Sepsis Detection
6.25. Presymptom Health Developing Test for Sepsis
6.26. Ortho Clinical Diagnostics Interleukin-6 Reagent Pack
6.27. Cytovale to Enter Sepsis Testing Market
6.28. Baebies Awarded $11.6M to Develop Diagnostic Platform to ID Sepsis
6.29. Personalized Medicine in Sepsis
6.30. Point-of-care Device can Diagnose Sepsis in 30 Minutes
6.31. SpeeDx Developing Respiratory Virus Host-Response Test
6.32. Scanogen Developing Blood Infection Test with Sepsis Application
6.33. Inflammatix Developing New Sepsis Dx
6.34. Immunexpress, Biocartis to Roll Out Sepsis Test
6.35. Sepset Biosciences Using COVID-19 Patient Samples to Validate Sepsis Test
6.36. Immunexpress to Develop Sepsis Test
6.37. DNAe Developing POC Sequencing for Sepsis
6.38. NGS technique offers quick, accurate diagnosis of Sepsis
6.39. Portable device diagnoses sepsis faster

7. Profiles of Key Companies

7.1. Abbott Laboratories
7.2. Abionic
7.3. Accel Diagnostics
7.4. Accelerate Diagnostics
7.5. ADT Biotech
7.6. Anatolia Geneworks
7.7. Axis-Shield Diagnostics Ltd.
7.8. Baebies
7.9. Beckman Coulter Diagnostics
7.10. Becton, Dickinson and Company
7.11. Biocartis
7.12. BioFire Diagnostics (bioMerieux)
7.13. bioMerieux Diagnostics
7.14. Bio-Rad Laboratories, Inc.
7.15. Bruker
7.16. Cube Dx
7.17. Curetis N.V. / Curetis GmbH
7.18. Cytovale
7.19. Deepull Diagnostics
7.20. DNAe
7.21. EKF Diagnostics Holdings
7.22. GeneFluidics
7.23. GenMark Dx (Roche)
7.24. Grifols
7.25. Immunexpress
7.26. Inflammatix
7.27. LightDeck Diagnostics
7.28. Linear Diagnostics
7.29. Luminex Corp (DiaSorin)
7.30. Mobidiag (Hologic)
7.31. NanoDx
7.32. Nanomix
7.33. Qiagen
7.34. Response Biomedical
7.35. Roche Molecular Diagnostics
7.36. SeLux Diagnostics
7.37. Septec
7.38. Siemens Healthineers
7.39. Sphingotec
7.40. T2 Biosystems
7.41. Thermo Fisher Scientific Inc.
7.42. Vela Diagnostics

8. Sepsis Global Diagnostic Markets Overview

8.1. Sepsis Diagnostics - Global Market Overview by Country
- 8.1.1. Table - Global Market by Country
- 8.1.2. Chart - Global Market by Country
8.2. Global Sepsis Diagnostics Markets Overview by Assay
- 8.2.1. Table - Global Market by Assay
- 8.2.2. Chart - Global Market by Assay - Segments Growth
- 8.2.3. Chart - Global Market by Assay - Share by Year
- 8.2.4. Chart - Global Market by Assay
- 8.2.5. Chart - Global Market by Assay - Base Year
- 8.2.6. Chart - Global Market by Assay - Final Year
8.3. Global Sepsis Diagnostics Markets Overview by Cause
- 8.3.1. Table - Global Market by Cause
- 8.3.2. Chart - Global Market by Cause - Segments Growth
- 8.3.3. Chart - Global Market by Cause - Share by Year
- 8.3.4. Chart - Global Market by Cause
- 8.3.5. Chart - Global Market by Cause - Base Year
- 8.3.6. Chart - Global Market by Cause - Final Year
8.4. Global Sepsis Diagnostics Markets Overview by Product
- 8.4.1. Table - Global Market by Product
- 8.4.2. Chart - Global Market by Product - Segments Growth
- 8.4.3. Chart - Global Market by Product - Share by Year
- 8.4.4. Chart - Global Market by Product
- 8.4.5. Chart - Global Market by Product - Base Year
- 8.4.6. Chart - Global Market by Product - Final Year
8.5. Global Sepsis Diagnostics Markets Overview by Lab
- 8.5.1. Table - Global Market by Lab
- 8.5.2. Chart - Global Market by Lab - Segments Growth
- 8.5.3. Chart - Global Market by Lab - Share by Year
- 8.5.4. Chart - Global Market by Lab
- 8.5.5. Chart - Global Market by Lab - Base Year
- 8.5.6. Chart - Global Market by Lab - Final Year
8.6. Global Sepsis Diagnostics Markets Overview by Place
- 8.6.1. Table - Global Market by Place
- 8.6.2. Chart - Global Market by Place - Segments Growth
- 8.6.3. Chart - Global Market by Place - Share by Year
- 8.6.4. Chart - Global Market by Place
- 8.6.5. Chart - Global Market by Place - Base Year
- 8.6.6. Chart - Global Market by Place - Final Year

9. Sepsis Diagnostic Market - by Assay

9.1. Sepsis Diagnostic - Microbiology
- 9.1.1. Table Sepsis Diagnostic Microbiology - by Country
- 9.1.2. Chart - Sepsis Diagnostic Microbiology Growth
9.2. Sepsis Diagnostic - PCR
- 9.2.1. Table Sepsis Diagnostic PCR - by Country
- 9.2.2. Chart - Sepsis Diagnostic PCR Growth
9.3. Sepsis Diagnostic - Immunoassay
- 9.3.1. Table Sepsis Diagnostic Immunoassay - by Country
- 9.3.2. Chart - Sepsis Diagnostic - Immunoassay Growth
9.4. Sepsis Diagnostic - Infectious Disease Other
- 9.4.1. Table Sepsis Diagnostic Infectious Disease Other - by Country
- 9.4.2. Chart - Sepsis Diagnostic - Infectious Disease Other Growth
9.5. Sepsis Diagnostic - Biomarker MDx
- 9.5.1. Table Sepsis Diagnostic Biomarker MDx - by Country
- 9.5.2. Chart - Sepsis Diagnostic - Biomarker MDx Growth
9.6. Sepsis Diagnostic - Biomarker Other
- 9.6.1. Table Sepsis Diagnostic Biomarker Other - by Country
- 9.6.2. Chart - Sepsis Diagnostic - Biomarker Other Growth

10. Global Sepsis Diagnostics Markets - By Cause

10.1. Sepsis Diagnostic - GastroIntestinal
- 10.1.1. Table Sepsis Diagnostic GastroIntestinal - by Country
- 10.1.2. Chart - Sepsis Diagnostic GastroIntestinal Growth
10.2. Sepsis Diagnostic - Respiratory COVID-19
- 10.2.1. Table Sepsis Diagnostic Respiratory COVID-19- by Country
- 10.2.2. Chart - Sepsis Diagnostic Respiratory COVID-19
10.3. Sepsis Diagnostic - Respiratory Other
- 10.3.1. Table Sepsis Diagnostic Respiratory Other - by Country
- 10.3.2. Chart - Sepsis Diagnostic - Respiratory Other Growth
10.4. Sepsis Diagnostic - Neonatal
- 10.4.1. Table Sepsis Diagnostic Neonatal - by Country
- 10.4.2. Chart - Sepsis Diagnostic - Neonatal Growth
10.5. Sepsis Diagnostic - Other Cause
- 10.5.1. Table Sepsis Diagnostic Other Cause - by Country
- 10.5.2. Chart - Sepsis Diagnostic - Other Cause Growth

11. Global Sepsis Diagnostics Markets - By Product

11.1. Sepsis Diagnostic - Instrumentation
- 11.1.1. Table Sepsis Diagnostic Instrumentation - by Country
- 11.1.2. Chart - Sepsis Diagnostic Instrumentation Growth
11.2. Sepsis Diagnostic - Consumables
- 11.2.1. Table Sepsis Diagnostic Consumables - by Country
- 11.2.2. Chart - Sepsis Diagnostic Consumables
11.3. Sepsis Diagnostic - Software & Service
- 11.3.1. Table Sepsis Diagnostic Software & Service - by Country
- 11.3.2. Chart - Sepsis Diagnostic - Software & Service Growth

12. Global Sepsis Diagnostics Markets - By Lab

12.1. Sepsis Diagnostic - In Lab
- 12.1.1. Table Sepsis Diagnostic In Lab - by Country
- 12.1.2. Chart - Sepsis Diagnostic In Lab Growth
12.2. Sepsis Diagnostic - Point of Care
- 12.2.1. Table Sepsis Diagnostic Point of Care - by Country
- 12.2.2. Chart - Sepsis Diagnostic Point of Care

13. Global Sepsis Diagnostics Markets - By Place

13.1. Sepsis Diagnostic - Hospital
- 13.1.1. Table Sepsis Diagnostic Hospital - by Country
- 13.1.2. Chart - Sepsis Diagnostic Hospital Growth
13.2. Sepsis Diagnostic - Other Place
- 13.2.1. Table Sepsis Diagnostic Other Place - by Country
- 13.2.2. Chart - Sepsis Diagnostic Other Place

14. Appendices

14.1. United States Medicare System: Clinical Laboratory Fees Schedule
14.2. The Most Used IVD Assays
14.3. The Highest Grossing Assays

Table of Tables

Table 1: sepsis biomarkers - Established and potential
Table 2: Market Players by Type
Table 3: Five Factors Driving Growth
Table 4: Three Factors Limiting Growth
Table 5: Seven Key Diagnostic Laboratory Technology Trends
Table 6 - Global Sepsis Diagnostics Market by Country/Region
Table 7: Global Market by Assay
Table 8: Global Market by Cause
Table 9: Global Market by Product
Table 10: Global Market by Lab
Table 11: Global Market by Place
Table 12: Sepsis Diagnostic Microbiology by Country
Table 13: Sepsis Diagnostic PCR by Country
Table 14: Sepsis Diagnostic Immunoassay by Country
Table 15: Sepsis Diagnostic Infectious Disease Other by Country
Table 16: Sepsis Diagnostic Biomarker MDx by Country
Table 17: Sepsis Diagnostic Biomarker Other by Country
Table 18: Sepsis Diagnostic GastroIntestinal by Country
Table 19: Sepsis Diagnostic Respiratory COVID-19 by Country
Table 20: Sepsis Diagnostic Respiratory Other by Country
Table 21: Sepsis Diagnostic Neonatal by Country
Table 22: Sepsis Diagnostic Other Cause by Country
Table 23: Sepsis Diagnostic Instrumentation by Country
Table 24: Sepsis Diagnostic Consumables by Country
Table 25: Sepsis Diagnostic Software & Service by Country
Table 26: Sepsis Diagnostic In Lab by Country
Table 27: Sepsis Diagnostic Point of Care by Country
Table 28: Sepsis Diagnostic Hospital by Country
Table 29: Sepsis Diagnostic Other Place by Country
Table 30: Clinical Lab Fee Schedule
Table 31: The Most Common Assays
Table 32: Largest Revenue Assays

Table of Figures

Figure 1: Sepsis Survival graph
Figure 2: Percentage of Sepsis Patients with Comorbidity
Figure 3: Global Healthcare Spending
Figure 4: The Lab Test Pie
Figure 5: Sepsis Clinical Progression
Figure 6: The Road to Diagnostics
Figure 7: Deaths From Drug Resistant Infections 2050
Figure 8: The Changing Age of The World's Population
Figure 9: Health Care Consumption by Age
Figure 10: Cancer Incidence - Age at Diagnosis
Figure 11: Growth in Health Care Spending Developing World
Figure 12: Centralized vs. Decentralized Laboratory Service
Figure 13: A Highly Multiplexed Syndromic Testing Unit
Figure 14: The Real Cost to Sequence the Human Genome
Figure 15: The Codevelopment Process
Figure 16: Comparing MDx Diagnostic and Traditional Testing
Figure 17: Growth rates of Sepsis Diagnostics
Figure 18: Global Market Share Chart
Figure 19: Sepsis Diagnostics Market Segment Shift Base vs Final year
Figure 20: Sepsis Diagnostics Market by Assay Base Year
Figure 21: Sepsis Diagnostics Market by Assay Final Year
Figure 22: Sepsis Diagnostics Market Segment Shift Base vs Final year
Figure 23: Sepsis Diagnostics Market by Cause Base Year
Figure 24: Sepsis Diagnostics Market by Cause Final Year
Figure 25: Sepsis Diagnostics Market Segment Shift Base vs Final year
Figure 26: Sepsis Diagnostics Market by Product Base Year
Figure 27: Sepsis Diagnostics Market by Product Final Year
Figure 28: Sepsis Diagnostics Market Segment Shift Base vs Final year
Figure 29: Sepsis Diagnostics Market by Lab Base Year
Figure 30: Sepsis Diagnostics Market by Lab Final Year
Figure 31: Sepsis Diagnostics Market Segment Shift Base vs Final year
Figure 32: Sepsis Diagnostics Market by Place Base Year
Figure 33: Sepsis Diagnostics Market by Place Final Year
Figure 34: Sepsis Diagnostic Microbiology Growth
Figure 35: Sepsis Diagnostics Syndromic POC Panel Growth
Figure 36: Sepsis Diagnostic Immunoassay Growth
Figure 37: Sepsis Diagnostic Infectious Disease Other Growth
Figure 38: Sepsis Diagnostic Biomarker MDx Growth
Figure 39: Sepsis Diagnostic Biomarker Other Growth
Figure 40: Sepsis Diagnostic GastroIntestinal Growth
Figure 41: Sepsis Diagnostics Respiratory COVID-19
Figure 42: Sepsis Diagnostic Respiratory Other Growth
Figure 43: Sepsis Diagnostic Neonatal Growth
Figure 44: Sepsis Diagnostic Other Cause Growth
Figure 45: Sepsis Diagnostic Instrumentation Growth
Figure 46: Sepsis Diagnostics Consumables
Figure 47: Sepsis Diagnostic Software & Service Growth
Figure 48: Sepsis Diagnostic In Lab Growth
Figure 49: Sepsis Diagnostics Point of Care
Figure 50: Sepsis Diagnostic GastroIntestinal Growth
Figure 51: Sepsis Diagnostics Other Place

Sepsis Diagnostic Markets. Global Market Forecasts by Assay, by Cause, by Product, by Lab, and by Place. With Executive and Consultant Guides. 2025 - 2029

Description

Table of Contents

List of Tables

Report Overview: